NATIONAL RESEARCH CORPNRC
| Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
---|
Cash and cash equivalents | 8 | 8 | 22 | 40 | 42 | 33 | 35 | 13 | 14 | 35 | 54 | 25 | 7 |
---|
Trade accounts receivable | 11 | 12 | 11 | 8 | 10 | 11 | 13 | 12 | 12 | 14 | 14 | 14 | 12 |
---|
Prepaid expenses | - | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 2 | 3 | 4 | 2 | 4 |
---|
Income taxes receivable | - | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
---|
Other current assets | - | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 2 | 1 | 1 | 1 |
---|
Total current assets | 22 | 24 | 36 | 53 | 56 | 47 | 52 | 28 | 29 | 54 | 74 | 44 | 24 |
---|
Net property and equipment | 14 | 12 | 12 | 12 | 11 | 12 | 12 | 14 | 14 | 12 | 12 | 17 | 28 |
---|
Intangible assets, net | 7 | 6 | 5 | 5 | 4 | 3 | 3 | 2 | 2 | 1 | 2 | 2 | 1 |
---|
Goodwill | 58 | 58 | 58 | 58 | 58 | 58 | 58 | 58 | 58 | 57 | 62 | 62 | 62 |
---|
Operating lease right-of-use assets | - | - | - | - | - | - | - | - | 2 | 1 | 1 | 1 | 2 |
---|
Deferred contract costs, net | - | - | - | - | - | - | - | 3 | 4 | 5 | 4 | 2 | 2 |
---|
Deferred income taxes | - | - | - | - | - | - | - | - | - | - | 0 | 0 | - |
---|
Other Assets, Noncurrent | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 3 | 3 | 3 | 3 | 3 |
---|
Total assets | 101 | 100 | 111 | 130 | 129 | 121 | 127 | 108 | 111 | 133 | 158 | 130 | 122 |
---|
Current portion of notes payable, net of unamortized debt issuance costs | - | - | - | 2 | 2 | 3 | 1 | 4 | 4 | 4 | 4 | 4 | 7 |
---|
Accounts payable | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
---|
Accrued wages and bonuses | 4 | 4 | 4 | 4 | 4 | 5 | 7 | 6 | 6 | 6 | 7 | 5 | 4 |
---|
Accrued expenses | 2 | 2 | 2 | 5 | 3 | 3 | 3 | 3 | 3 | 3 | 5 | 4 | 5 |
---|
Dividends payable | - | - | - | - | 18 | 4 | 4 | 17 | 5 | - | 3 | 3 | 3 |
---|
Deferred revenue | - | - | - | - | - | - | - | 16 | 16 | 16 | 17 | 15 | 15 |
---|
Other current liabilities | - | - | - | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
---|
Income Taxes Payable | 0 | - | - | 0 | 1 | 1 | - | 1 | 0 | - | - | - | 0 |
---|
Total current liabilities | 24 | 35 | 24 | 28 | 44 | 32 | 32 | 47 | 38 | 32 | 40 | 33 | 36 |
---|
Other current liabilities | - | - | - | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
---|
Notes payable, net of current portion and unamortized debt issuance costs | 13 | - | 8 | 6 | 3 | 1 | - | 34 | 30 | 27 | 22 | 18 | 29 |
---|
Total current liabilities | 24 | 35 | 24 | 28 | 44 | 32 | 32 | 47 | 38 | 32 | 40 | 33 | 36 |
---|
Deferred income taxes | - | - | - | - | - | - | - | - | 7 | 7 | 7 | 5 | 4 |
---|
Notes payable, net of current portion and unamortized debt issuance costs | 13 | - | 8 | 6 | 3 | 1 | - | 34 | 30 | 27 | 22 | 18 | 29 |
---|
Other long-term liabilities | - | - | - | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 3 | 2 | 4 |
---|
Deferred income taxes | - | - | - | - | - | - | - | - | 7 | 7 | 7 | 5 | 4 |
---|
Total liabilities | 45 | 43 | 39 | 42 | 54,877,000 | 38 | 37 | 89 | 78 | 69 | 72 | 58 | 73 |
---|
Other long-term liabilities | - | - | - | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 3 | 2 | 4 |
---|
Total liabilities | 45 | 43 | 39 | 42 | 54,877,000 | 38 | 37 | 89 | 78 | 69 | 72 | 58 | 73 |
---|
Preferred stock, $0.01 par value, authorized 2,000,000 shares, none issued | - | - | - | - | - | - | - | - | - | - | - | - | - |
---|
Common stock, $0.001 par value; authorized 110,000,000 shares, issued 31,002,919 in 2023 and 30,922,181 in 2022, outstanding 24,219,887 in 2023 and 24,628,173 in 2022 | 0 | 0 | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
---|
Additional paid-in capital | 31 | 40 | 42 | 45 | 44 | 47 | 51 | 157 | 162 | 172 | 174 | 175 | 178 |
---|
Retained earnings (accumulated deficit) | 47 | 45 | 58 | 74 | 65 | 72 | 78 | -106 | -93 | -61 | -36 | -25 | -31 |
---|
Accumulated other comprehensive loss, foreign currency translation adjustment | - | - | - | - | -3 | -3 | -2 | -3 | -2 | -2 | -2 | - | - |
---|
Treasury stock, at cost; 6,783,032 Common shares in 2023 and 6,294,008 Common shares in 2022 | 23 | 29 | 29 | 30 | 32 | 33 | 37 | 29 | 34 | 44 | 50 | 78 | 99 |
---|
Total shareholders’ equity | 56 | 57 | 72 | 88 | 74,222,000 | 83 | 90 | 19 | 33 | 64 | 85 | 72 | 49 |
---|
Total liabilities and shareholders’ equity | 101 | 100 | 111 | 130 | 129 | 121 | 127 | 108 | 111 | 133 | 158 | 130 | 122 |
---|